| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | NMRA | Stock Option (Right to Buy) | Disposed to Issuer | -502,934 | -100% | 0 | 13 Feb 2025 | Common Stock | 502,934 | $17.00 | Direct | F1, F2 | ||
| transaction | NMRA | Stock Option (Right to Buy) | Disposed to Issuer | -100,000 | -100% | 0 | 13 Feb 2025 | Common Stock | 100,000 | $18.07 | Direct | F2, F3 | ||
| transaction | NMRA | Stock Option (Right to Buy) | Award | +502,934 | 502,934 | 13 Feb 2025 | Common Stock | 502,934 | $1.69 | Direct | F1, F2, F4 | |||
| transaction | NMRA | Stock Option (Right to Buy) | Award | +100,000 | 100,000 | 13 Feb 2025 | Common Stock | 100,000 | $1.69 | Direct | F2, F3, F4 |
| Id | Content |
|---|---|
| F1 | 25% of the shares subject to the option vest on the first anniversary measured from September 11, 2023 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| F2 | On February 13, 2025, the Board approved the repricing of the option. As further described in footnote 4, all other terms of the option remain unchanged. |
| F3 | 25% of the shares subject to the option vest on the first anniversary measured from February 14, 2024 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. |
| F4 | Effective February 13, 2025, subject to and contingent on the approval by the Issuer's stockholders, the Board approved an option repricing with an exercise price of $1.69 per share (the "Repricing") of the outstanding stock options held by members of the Board, certain employees and other service providers, provided that if the requisite approval of the Issuer's stockholders is not obtained, the Repricing will be void and the terms of each repriced option shall continue to be subject to its original terms and conditions, including, without limitation, the per share exercise price. The Repricing is subject to the Reporting Person remaining in service to the Issuer through August 13, 2026. |